64 related articles for article (PubMed ID: 17548494)
41. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
Hof H
Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827
[TBL] [Abstract][Full Text] [Related]
42. Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance.
Castelo-Branco D; Lockhart SR; Chen YC; Santos DA; Hagen F; Hawkins NJ; Lavergne RA; Meis JF; Le Pape P; Rocha MFG; Sidrim JJC; Arendrup M; Morio F
Mycoses; 2022 Mar; 65(3):303-311. PubMed ID: 34821412
[TBL] [Abstract][Full Text] [Related]
43. Azole resistance in Aspergillus: global status in Europe and Asia.
Arikan-Akdagli S
Ann N Y Acad Sci; 2012 Dec; 1272():9-14. PubMed ID: 23231709
[TBL] [Abstract][Full Text] [Related]
44. Antifungal resistance in yeast vaginitis.
Dun E
Yale J Biol Med; 1999; 72(4):281-5. PubMed ID: 10907778
[TBL] [Abstract][Full Text] [Related]
45. Colonization of Candida species in denture wearers with emphasis on HIV infection: a literature review.
Perezous LF; Flaitz CM; Goldschmidt ME; Engelmeier RL
J Prosthet Dent; 2005 Mar; 93(3):288-93. PubMed ID: 15775931
[TBL] [Abstract][Full Text] [Related]
46. Azole fungicides - understanding resistance mechanisms in agricultural fungal pathogens.
Price CL; Parker JE; Warrilow AG; Kelly DE; Kelly SL
Pest Manag Sci; 2015 Aug; 71(8):1054-8. PubMed ID: 25914201
[TBL] [Abstract][Full Text] [Related]
47. Endogenous endophthalmitis with azole-resistant Candida albicans--Case report and review of the literature.
Osthoff M; Hilge R; Schulze-Döbold C; Bogner JR
Infection; 2006 Oct; 34(5):285-8. PubMed ID: 17033755
[TBL] [Abstract][Full Text] [Related]
48. Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond.
Bastos RW; Rossato L; Goldman GH; Santos DA
PLoS Pathog; 2021 Dec; 17(12):e1010073. PubMed ID: 34882756
[TBL] [Abstract][Full Text] [Related]
49. Critical annotations to the use of azole antifungals for plant protection.
Hof H
Antimicrob Agents Chemother; 2001 Nov; 45(11):2987-90. PubMed ID: 11600346
[No Abstract] [Full Text] [Related]
50. The changing mycology of candidiasis: new and resistant pathogens.
Rinaldi MG
AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S5-8; discussion S9. PubMed ID: 11361749
[No Abstract] [Full Text] [Related]
51. Impact of fungal drug transporters on fungicide sensitivity, multidrug resistance and virulence.
de Waard MA; Andrade AC; Hayashi K; Schoonbeek HJ; Stergiopoulos I; Zwiers LH
Pest Manag Sci; 2006 Mar; 62(3):195-207. PubMed ID: 16475240
[TBL] [Abstract][Full Text] [Related]
52. Oropharyngeal candidiasis in the era of antiretroviral therapy.
Thompson GR; Patel PK; Kirkpatrick WR; Westbrook SD; Berg D; Erlandsen J; Redding SW; Patterson TF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):488-95. PubMed ID: 20156694
[TBL] [Abstract][Full Text] [Related]
53. Candidiasis (oropharyngeal).
Pankhurst C
Clin Evid; 2005 Jun; (13):1701-16. PubMed ID: 16135307
[No Abstract] [Full Text] [Related]
54. Candidiasis (oropharyngeal).
Pankhurst C
Clin Evid; 2004 Dec; (12):1906-23. PubMed ID: 15865758
[No Abstract] [Full Text] [Related]
55. Fungal infections associated with HIV infection.
Samaranayake LP; Fidel PL; Naglik JR; Sweet SP; Teanpaisan R; Coogan MM; Blignaut E; Wanzala P
Oral Dis; 2002; 8 Suppl 2():151-60. PubMed ID: 12164650
[TBL] [Abstract][Full Text] [Related]
56. [Criteria for sensitivity to azoles].
Gil Tomás J; Rubio Calvo C; Benito Ruesca R
Rev Esp Quimioter; 2004 Mar; 17(1):83-90. PubMed ID: 15201929
[No Abstract] [Full Text] [Related]
57. [The mechanisms of antifungal drug resistance and novel antifungal agents].
Leng P; Guo XL; Lou HX
Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):325-8. PubMed ID: 16408772
[No Abstract] [Full Text] [Related]
58. Biocides: mechanisms of antifungal action and fungal resistance.
Russell AD; Furr JR
Sci Prog; 1996; 79 ( Pt 1)():27-48. PubMed ID: 8693327
[No Abstract] [Full Text] [Related]
59. Candidiasis (oropharyngeal).
Pankhurst CL
Clin Evid; 2006 Jun; (15):1849-63. PubMed ID: 16973067
[No Abstract] [Full Text] [Related]
60. Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Müller FM; Staudigel A; Salvenmoser S; Tredup A; Miltenberger R; Herrmann JV
Antimicrob Agents Chemother; 2007 Aug; 51(8):3014-6. PubMed ID: 17548494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
